Clinical trial / 2018
Oral taurine supplementation (2 g/day) reduced the frequency, duration, and severity of muscle cramps in patients with chronic liver disease.
In a double-blind, randomized crossover trial, patients with chronic liver disease and frequent muscle cramps received either oral taurine or placebo for 4 weeks before crossing over. Out of 49 enrolled patients, 30 completed the protocol and were included in the final analysis. Compared to placebo, supplementation with 2 g taurine/day led to fewer cramps (7 fewer/fortnight, P = 0.03), reduced duration (89 minutes less/fortnight, P = 0.03), and reduced severity (1.4 units less on a Likert scale, P < 0.004). Oral taurine significantly increased serum taurine levels (P < 0.001) without adverse side effects.
- Study type
- Double-blinded randomized controlled crossover trial
- Who was studied
- 49 patients with chronic liver disease experiencing 3+ muscle cramps/week enrolled (30 completed)
- What was measured
- Frequency, duration, and intensity of muscle cramps; serum taurine and methionine levels
THE PAPER
Randomised clinical trial: oral taurine supplementation versus placebo reduces muscle cramps in patients with chronic liver disease.
Vidot H, Cvejic E, Carey S, Strasser SI, McCaughan GW, Allman-Farinelli M, Shackel NA. Aliment Pharmacol Ther, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.